Cargando…
Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
Autophagy regenerates cellular nutrients, recycles metabolites, and maintains hemostasis through multistep signaling pathways, in conjunction with lysosomal degradation mechanisms. In tumor cells, autophagy has been shown to play a dual role as both tumor suppressor and tumor promoter, leading to th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196239/ https://www.ncbi.nlm.nih.gov/pubmed/37213283 http://dx.doi.org/10.3389/fonc.2023.1150492 |
_version_ | 1785044304126803968 |
---|---|
author | Gharoonpour, Azar Simiyari, Dorsa Yousefzadeh, Ali Badragheh, Fatemeh Rahmati, Marveh |
author_facet | Gharoonpour, Azar Simiyari, Dorsa Yousefzadeh, Ali Badragheh, Fatemeh Rahmati, Marveh |
author_sort | Gharoonpour, Azar |
collection | PubMed |
description | Autophagy regenerates cellular nutrients, recycles metabolites, and maintains hemostasis through multistep signaling pathways, in conjunction with lysosomal degradation mechanisms. In tumor cells, autophagy has been shown to play a dual role as both tumor suppressor and tumor promoter, leading to the discovery of new therapeutic strategies for cancer. Therefore, regulation of autophagy is essential during cancer progression. In this regard, the use of nanoparticles (NPs) is a promising technique in the clinic to modulate autophagy pathways. Here, we summarized the importance of breast cancer worldwide, and we discussed its classification, current treatment strategies, and the strengths and weaknesses of available treatments. We have also described the application of NPs and nanocarriers (NCs) in breast cancer treatment and their capability to modulate autophagy. Then the advantages and disadvantaged of NPs in cancer therapy along with future applications will be disscussed. The purpose of this review is to provide up-to-date information on NPs used in breast cancer treatment and their impacts on autophagy pathways for researchers. |
format | Online Article Text |
id | pubmed-10196239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101962392023-05-20 Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles Gharoonpour, Azar Simiyari, Dorsa Yousefzadeh, Ali Badragheh, Fatemeh Rahmati, Marveh Front Oncol Oncology Autophagy regenerates cellular nutrients, recycles metabolites, and maintains hemostasis through multistep signaling pathways, in conjunction with lysosomal degradation mechanisms. In tumor cells, autophagy has been shown to play a dual role as both tumor suppressor and tumor promoter, leading to the discovery of new therapeutic strategies for cancer. Therefore, regulation of autophagy is essential during cancer progression. In this regard, the use of nanoparticles (NPs) is a promising technique in the clinic to modulate autophagy pathways. Here, we summarized the importance of breast cancer worldwide, and we discussed its classification, current treatment strategies, and the strengths and weaknesses of available treatments. We have also described the application of NPs and nanocarriers (NCs) in breast cancer treatment and their capability to modulate autophagy. Then the advantages and disadvantaged of NPs in cancer therapy along with future applications will be disscussed. The purpose of this review is to provide up-to-date information on NPs used in breast cancer treatment and their impacts on autophagy pathways for researchers. Frontiers Media S.A. 2023-05-05 /pmc/articles/PMC10196239/ /pubmed/37213283 http://dx.doi.org/10.3389/fonc.2023.1150492 Text en Copyright © 2023 Gharoonpour, Simiyari, Yousefzadeh, Badragheh and Rahmati https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Gharoonpour, Azar Simiyari, Dorsa Yousefzadeh, Ali Badragheh, Fatemeh Rahmati, Marveh Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles |
title | Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles |
title_full | Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles |
title_fullStr | Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles |
title_full_unstemmed | Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles |
title_short | Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles |
title_sort | autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196239/ https://www.ncbi.nlm.nih.gov/pubmed/37213283 http://dx.doi.org/10.3389/fonc.2023.1150492 |
work_keys_str_mv | AT gharoonpourazar autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles AT simiyaridorsa autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles AT yousefzadehali autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles AT badraghehfatemeh autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles AT rahmatimarveh autophagymodulationinbreastcancerutilizingnanomaterialsandnanoparticles |